NBIX icon

Neurocrine Biosciences

133 hedge funds and large institutions have $1.88B invested in Neurocrine Biosciences in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 11 closing their positions.

Holders
133
Holders Change
+8
Holders Change %
+6.4%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
19
Increased
44
Reduced
42
Closed
11
Calls
$20M
Puts
$17.7M
Net Calls
+$2.3M
Net Calls Change
-$709K
Name Holding Trade Value Shares
Change
Shares
Change %
Ameriprise
126
Ameriprise
Minnesota
$6K +$78 +5 +1%
S
127
SignatureFD
Georgia
$3K
BPBT
128
Boston Private Bank & Trust
Massachusetts
$3K
US Bancorp
129
US Bancorp
Minnesota
$3K
PNC Financial Services Group
130
PNC Financial Services Group
Pennsylvania
$3K
GSC
131
Ground Swell Capital
South Carolina
$2K +$2K +150 New
Envestnet Asset Management
132
Envestnet Asset Management
Illinois
$1K
LTFS
133
Ladenburg Thalmann Financial Services
Florida
$1K
Manulife (Manufacturers Life Insurance)
134
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$770 +$16 +1,041 +2%
TI
135
Turner Investments
Pennsylvania
-$4.51M -303,950 Closed
Aviva
136
Aviva
United Kingdom
-$1.85M -124,427 Closed
RCM
137
RA Capital Management
Massachusetts
-$1.02M -68,968 Closed
DM
138
Deerfield Management
New York
-$788K -53,094 Closed
Zurich Cantonal Bank
139
Zurich Cantonal Bank
Switzerland
-$668K -45,000 Closed
SCA
140
Secor Capital Advisors
New York
-$488K -32,877 Closed
LCM
141
Laurion Capital Management
New York
-$424K -28,600 Closed
BAAM
142
Baker Avenue Asset Management
California
-$267K -17,980 Closed
GCP
143
GSA Capital Partners
United Kingdom
-$255K -17,211 Closed
SCM
144
Stevens Capital Management
Pennsylvania
-$170K -11,481 Closed
Bank of Montreal
145
Bank of Montreal
Ontario, Canada
-$28K -1,860 Closed